DTRA Funding
The Defense Threat Reduction Agency (DTRA) provides funding opportunities focused on countering threats posed by weapons of mass destruction (WMDs), including nuclear, biological, chemical, and radiological weapons. These opportunities are typically available through Broad Agency Announcements (BAAs), Small Business Innovation Research (SBIR) programs, and other solicitations, which outline specific research and development interests.
About DTRA
Initial solicitation response steps typically involve drafting a white paper outlining the proposed effort without detailed delivery schedules or cost estimates. DTRA requests that white papers should focus on technical merits and feasibility of the project, including research and development efforts to determine the feasibility of the proposed solution. The DTRA SBIR/STTR Selection Authority will review and approve those white papers selected to move forward to a full proposal.
DTRA encourages participation from a diverse range of entities, including educational institutions, nonprofit organizations, and businesses of all sizes, particularly those with innovative solutions that can help detect, deter, and neutralize WMD threats.
EverGlade's solutions include:
- Opportunity identification
- Portfolio review
- Proposal support
- Post-award program management
- Post-Award contract administration
Download the Guide to DTRA Funding
Recent DTRA Funding Programs
DTRA Topic Call 7: Advanced Bioaerosol Triggers and Engineered Genome Detection
Deep Dive Into DTRA’s Six Basic Research Topics
Advancing Biodefense Readiness: MTEC and DTRA’s Multi-Topic RPP
DTRA–MTEC Pre-Announcement for Biodefense Readiness RPP
DTRA’s “Plume” RFI for Marine Toxin Aerosol Exposure Models
DTRA’s Reimagining the Next Generation of Biodefense Vaccines
MCDC Announces “Increased Micro Sampling to Monitor Immunological Response” RPP
MCDC Releases “Defined Rapid Antigen Identification and Immunogenic Characterization” RPP
DTRA’s RAVEN RFI Seeks Multivalent Vaccine Innovation
Advancing Chemical Threat Readiness: The MCDC’s New Call for Prototypes
Project UPREG
Assay Expansion for Chemical Diagnostic System
Why EverGlade?
Federal funding is our science. We create, support, and manage strategic partnerships between innovators and funding agencies to maximize the impact of investment dollars while accelerating our clients’ growth.
Ready to Pursue DTRA Funding?
Have a question or ready to discuss your project? Our team can help determine eligibility, align your proposal with agency priorities, and guide you through every step of the process.
DTRA Funding FAQ
The Defense Threat Reduction Agency (DTRA) is a DoD agency that funds solutions to deter, prevent, and counter weapons of mass destruction (WMD) and emerging threats, including medical countermeasures, biodefense, and CBRN readiness. Funding often flows through BAAs and consortium mechanisms such as MTEC. EverGlade helps innovators align their technology to DTRA's mission areas and compete effectively.
Yes, DTRA works with startups, small businesses, universities, and established companies developing counter-WMD and CBRN defense technologies, often through SBIR and STTR programs designed for nontraditional innovators. Eligibility varies by specific solicitation. EverGlade helps startups position their technology for DTRA's mission-critical priorities.
BARDA focuses on protecting public health through medical countermeasures and health security programs, while DTRA focuses specifically on protecting military personnel against chemical, biological, radiological, and nuclear threats. Organizations developing medical countermeasures may qualify for funding from both agencies. EverGlade helps companies pursue both pathways strategically when their technology fits.